+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Biologics Market: Analysis By Product Type, Application Type, Product Pipeline, End User, By Region, By Country (2020 Edition): Market Insight, Competition and Forecast (2020-2025)

  • ID: 4992430
  • Report
  • February 2020
  • Region: Global
  • 234 pages
  • Azoth Analytics
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • AbbVie Inc
  • Amgen Inc
  • and Johnson & Johnson.
  • Eli Lily and Company
  • Merck & Co
  • Novo Nordisk
  • MORE
Executive Summary

Global Biologics Market was valued at USD 281.69 billion in the year 2019. Growing development of pipeline products and rapid economic growth with rising prevalence of chronic diseases and surging demand for low cost biologics and medical services, will be accelerating the biologics market growth. All prominent pharmaceutical companies around the world are making their own efforts to deliver biologics which could meet the demand of productive, efficient and inexpensive medicine for various chronic untreatable diseases. Furthermore, efficacy and safety of biologics medicine, in addition to having a capacity to treat previously grave diseases, is one of the key driving factor which has anticipated to propel the market value in forecast period.

Under the product type segment, Monoclonal Antibodies followed by Recombinant Hormones and Proteins will be attaining sustainable market growth owing to wide availability and development of medicines and technology that helps in biologics supported by availability of proficient and cost-effective manufacturing process that will be facilitating the market growth during the forecasting period.

Cancer and Hospitals secured considerable market growth under their respective segments, owing to escalating investment by hospitals in providing treatment for some long-term medical conditions, including rheumatoid arthritis, Crohn's disease, psoriasis and ankylosing spondylitis and ever growing number of patients who are suffering from cancer.

Among the regions, North America attained sustainable market growth followed by Europe and Asia Pacific. Rising prevalence of chronic diseases such as cancer, diabetes, hypertension, stroke, heart disease, respiratory diseases, arthritis, obesity, and oral diseases in North America clubbed with growing investment by various global manufacturers in North America in order to attract the market growth, has been forecasted to boost the biologics market growth during the forecast period of 2020-2025.

Scope of the Report
  • The report analyses biologics market at global, regional and country-levels.
  • The report analyses Biologics Market by Product Type (Vaccines, Monoclonal Antibodies, Recombinant Hormones/Proteins, Cellular & Gene based, Others).
  • The report assesses the Biologics market By Application (Cancer, Rare and Auto-immune Diseases, Infectious Diseases, Others).
  • The report further estimate the Biologics market By End User (Hospitals, Clinics, Diagnostic Centers, Others).
  • The Global Biologics Market has been analysed By Region (North America, Europe, Asia Pacific) and By Country (United States, Canada, Germany, France, UK, Italy, China, Japan, India, South Korea).
  • The report assesses the major pipeline products in biologics. Also, the attractiveness of the market has been presented by Region, Product Type, Application and End User. Additionally, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Eli Lily and Company, Sanofi SA, Pfizer, Roche Holding AG, AbbVie Inc, Amgen Inc, Merck & Co, Novo Nordisk, Bristol-Myers Squibb Company, and Johnson & Johnson.
  • The report presents the analysis of Biologics market for the historical period of 2015-2019 and the forecast period of 2020-2025.
Key Target Audience
  • Biologics companies
  • Pharmaceutical companies
  • Consulting and Advisory Firms
  • Investment Banks and Equity Firms
  • Government agenices
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie Inc
  • Amgen Inc
  • and Johnson & Johnson.
  • Eli Lily and Company
  • Merck & Co
  • Novo Nordisk
  • MORE
1. Research Methodology and Executive Summary
1.1 Research Methodology
1.2 Executive Summary

2. Strategic Recommendations
2.1 Focus on Investing in Biotech Research & Development for Next Generation Biologics
2.2 Focus on Demand for Affordability and Improved Access

3. Biologics Market : Product Outlook

4. Global Biologics Market: Sizing and Forecast
4.1 Market Size, By Value, Year 2015-2025

5. Global Biologics Market Segmentation - By Product Type, By Application, By End User
5.1 Competitive Scenario of Global Biologics: By Product Type
5.2 Vaccine - Market Size and Forecast (2015-2025)
5.3 Monoclonal Antibodies - Market Size and Forecast (2015-2025)
5.4 Recombinant Hormones and Proteins - Market Size and Forecast (2015-2025)
5.5 Cellular and Gene Based - Market Size and Forecast (2015-2025)\
5.6 Others - Market Size and Forecast (2015-2025)

6. Global Biologics Market Segmentation - By Application
6.1 Competitive Scenario of Global Biologics: By Application
6.2 Cancer - Market Size and Forecast (2015-2025)
6.3 Rare and Autoimmune Disease - Market Size and Forecast (2015-2025)
6.4 Infectious Diseases - Market Size and Forecast (2015-2025)
6.5 Others - Market Size and Forecast (2015-2025)

7. Global Biologics Market Segmentation - By End User
7.1 Competitive Scenario of Global Biologics: By End User
7.2 Hospitals - Market Size and Forecast (2015-2025)
7.3 Clinics - Market Size and Forecast (2015-2025)
7.4 Diagnostic Centers - Market Size and Forecast (2015-2025)
7.5 Others - Market Size and Forecast (2015-2025)

8. Global Biologics Market: Regional Analysis
8.1 Competitive Scenario of Global Biologics: By Region

9. North America Biologics Market: Segmentation By Product Type, By Application, By End User (2015-2025)
9.1 North America Biologics Market: Size and Forecast (2015-2025), By Value
9.2 North America Biologics Market - Prominent Companies
9.3 Market Segmentation By Product Type (Vaccine, Monoclonal Ab, Recombinant Hormones and Proteins, Cellular and Gene Based, Others)
9.4 Market Segmentation By Application (Cancer, Rare and Autoimmune Disease, Infectious Disease, Others)
9.5 Market Segmentation By End User (Hospital, Clinics, Diagnostic Centers, Others)
9.6 North America Biologics Market: Country Analysis
9.7 Market Opportunity Chart of North America Biologics Market - By Country, By Value, 2025
9.8 Competitive Scenario of North America Biologics: By Country
9.9 United States Biologics Market: Size and Forecast (2015-2025), By Value
9.10 United States Biologics Market Segmentation - By Product Type, By Application, By End User
9.11 Canada Biologics Market: Size and Forecast (2015-2025), By Value
9.12 Canada Biologics Market Segmentation - By Product Type, By Application, By End User

10. Europe Biologics Market: Segmentation By Product Type, By Application, By End User (2015-2025)
10.1 Europe Biologics Market: Size and Forecast (2015-2025), By Value
10.2 Europe Biologics Market - Prominent Companies
10.3 Market Segmentation By Product Type (Vaccine, Monoclonal Ab, Recombinant Hormones and Proteins, Cellular and Gene Based, Others)
10.4 Market Segmentation By Application (Cancer, Rare and Autoimmune Disease, Infectious Disease, Others)
10.5 Market Segmentation By End User (Hospital, Clinics, Diagnostic Centers, Others)
10.6 Europe Biologics Market: Country Analysis
10.7 Market Opportunity Chart of Europe Biologics Market - By Country, By Value, 2025
10.8 Competitive Scenario of North America Biologics: By Country
10.9 Germany Biologics Market: Size and Forecast (2015-2025), By Value
10.10 Germany Biologics Market Segmentation - By Product Type, By Application, By End User
10.11 France Biologics Market: Size and Forecast (2015-2025), By Value
10.12 France Biologics Market Segmentation - By Product Type, By Application, By End User
10.13 United Kingdom Biologics Market: Size and Forecast (2015-2025), By Value
10.14 United Kingdom Market Segmentation - By Product Type, By Application, By End User
10.15 Italy Biologics Market: Size and Forecast (2015-2025), By Value
10.16 Italy Biologics Market Segmentation - By Product Type, By Application, By End User

11. Asia Pacific Biologics Market: Segmentation By Product Type, By Application, By End User (2015-2025)
11.1 Asia Pacific Biologics Market: Size and Forecast (2015-2025), By Value
11.2 Asia Pacific Biologics Market - Prominent Companies
11.3 Market Segmentation By Product Type (Vaccine, Monoclonal Ab, Recombinant Hormones and Proteins, Cellular and Gene Based, Others)
11.4 Market Segmentation By Application (Cancer, Rare and Autoimmune Disease, Infectious Disease, Others)
11.5 Market Segmentation By End User (Hospital, Clinics, Diagnostic Centers, Others)
11.6 Asia Pacific Biologics Market: Country Analysis
11.7 Market Opportunity Chart of Asia Pacific Biologics Market - By Country, By Value, 2025
11.8 Competitive Scenario of Asia Pacific Biologics: By Country
11.9 China Biologics Market: Size and Forecast (2015-2025), By Value
11.10 China Biologics Market Segmentation - By Product Type, By Application, By End User
11.11 Japan Biologics Market: Size and Forecast (2015-2025), By Value
11.12 Japan Biologics Market Segmentation - By Product Type, By Application, By End User
11.13 India Biologics Market: Size and Forecast (2015-2025), By Value
11.14 India Biologics Market Segmentation - By Product Type, By Application, By End User
11.15 South Korea Biologics Market: Size and Forecast (2015-2025), By Value
11.16 South Korea Biologics Market Segmentation - By Product Type, By Application, By End User

12. Global Biologics Market Dynamics
12.1 Drivers
12.2 Restraints
12.3 Trends

13. Market Attractiveness
13.1 Market Attractiveness Chart of Global Biologics Market - By Product Type, 2025
13.2 Market Attractiveness Chart of Global Biologics Market - By Application, 2025
13.3 Market Attractiveness Chart of Global Biologics Market - By End User, 2025
13.4 Market Attractiveness Chart of Global Biologics Market - By Region, 2025

14. SWOT Analysis

15. Development of Pipeline Products

16. Competitive Landscape
16.1 Market Share Analysis

17. Company Profiles (Business Description, Financial Analysis, Business Strategy)
17.1 Eli Lilly and Company
17.2 Sanofi SA
17.3 Pfizer
17.4 Roche Holding AG
17.5 AbbVie Inc.
17.6 Amgen Inc.
17.7 Merck & Co.
17.8 Novo Nordisk
17.9 Bristol-Myers Squibb Company
17.10 Johnson & Johnson
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Eli Lily and Company
  • Sanofi SA
  • Pfizer
  • Roche Holding AG
  • AbbVie Inc
  • Amgen Inc
  • Merck & Co
  • Novo Nordisk
  • Bristol-Myers Squibb Company
  • and Johnson & Johnson.
Note: Product cover images may vary from those shown
5 of 4

Loading
LOADING...

Adroll
adroll